Ovid Therapeutics Inc. (OVID) Social Stream
Ovid Therapeutics Inc (OVID) Price Targets From Analysts
Use the tables below to see what analysts covering Ovid Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $7 | $4 | $4.75 | $3.38 | 40.53% |
The Trend in the Analyst Price Target
Over the past 29 weeks, OVID's average price target has gone down $1.25.
OVID reports an average of 77.32% for its upside potential over the past 16 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-07 | 4 | 7 | 4 | 4.75 | 3.50 | 35.71% |
| 2021-09-04 | 4 | 7 | 4 | 4.75 | 3.51 | 35.33% |
| 2021-08-28 | 4 | 7 | 4 | 4.75 | 3.52 | 34.94% |
| 2021-08-02 | 4 | 7 | 4 | 4.88 | 3.73 | 30.83% |
| 2021-08-01 | 4 | 7 | 4 | 4.88 | 3.73 | 30.83% |
| 2021-07-24 | 4 | 7 | 4 | 4.88 | 3.74 | 30.48% |
| 2021-07-17 | 4 | 7 | 4 | 4.88 | 3.70 | 31.89% |
| 2021-07-10 | 4 | 7 | 4 | 4.88 | 3.94 | 23.86% |
| 2021-07-03 | 4 | 7 | 4 | 4.88 | 4.04 | 20.79% |
| 2021-06-24 | 4 | 7 | 4 | 4.88 | 4.29 | 13.75% |
| 2021-06-13 | 4 | 8 | 4 | 5.88 | 4.49 | 30.96% |
| 2021-06-05 | 4 | 8 | 4 | 5.88 | 4.38 | 34.25% |
| 2021-05-03 | 4 | 8 | 4 | 6.00 | 3.73 | 60.86% |
| 2021-04-25 | 4 | 8 | 4 | 6.00 | 3.67 | 63.49% |
| 2021-04-17 | 4 | 8 | 5 | 6.25 | 3.78 | 65.34% |
| 2021-04-10 | 4 | 8 | 5 | 6.25 | 3.69 | 69.38% |
| 2021-04-03 | 4 | 8 | 5 | 6.25 | 4.07 | 53.56% |
| 2021-03-20 | 4 | 8 | 5 | 6.25 | 4.47 | 39.82% |
| 2021-03-02 | 4 | 8 | 4 | 6.00 | 2.96 | 102.7% |
| 2021-02-27 | 4 | 8 | 4 | 6.00 | 2.95 | 103.39% |
| 2021-02-20 | 4 | 8 | 4 | 6.00 | 3.47 | 72.91% |
| 2021-02-13 | 4 | 8 | 4 | 6.00 | 3.42 | 75.44% |
| 2021-02-06 | 4 | 8 | 4 | 6.00 | 3.19 | 88.09% |
| 2021-01-30 | 4 | 8 | 4 | 6.00 | 2.81 | 113.52% |
| 2021-01-23 | 4 | 8 | 4 | 6.00 | 2.71 | 121.4% |
| 2021-01-07 | 4 | 8 | 4 | 6.00 | 2.50 | 140% |
| 2020-12-30 | 4 | 8 | 4 | 6.00 | 2.38 | 152.1% |
| 2020-12-26 | 4 | 8 | 4 | 6.00 | 2.61 | 129.89% |
| 2020-12-19 | 4 | 8 | 4 | 6.00 | 2.65 | 126.42% |
| 2020-12-10 | 4 | 8 | 4 | 6.00 | 2.62 | 129.01% |
| 2020-12-07 | 4 | 8 | 4 | 6.00 | 2.58 | 132.56% |
| 2020-11-13 | 6 | 21 | 10 | 14.67 | 6.04 | 142.88% |
| 2020-09-29 | 6 | 21 | 10 | 14.83 | 5.98 | 147.99% |
| 2020-09-23 | 6 | 21 | 10 | 14.19 | 5.80 | 144.66% |
| 2020-08-25 | 6 | 21 | 10 | 14.19 | NA | NA% |
| 2020-08-10 | 6 | 21 | 9 | 13.52 | NA | NA% |
| 2020-07-31 | 6 | 21 | 9 | 12.96 | NA | NA% |
| 2020-07-21 | 5 | 21 | 9 | 13.60 | NA | NA% |
| 2020-07-13 | 5 | 21 | 9 | 13.60 | NA | NA% |
| 2020-07-05 | 5 | 20 | 8 | 13.00 | NA | NA% |
| 2020-06-17 | 6 | 20 | 8 | 12.43 | NA | NA% |
| 2020-05-14 | 6 | 20 | 7 | 11.43 | NA | NA% |
OVID Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.58 | 2 | 1 | 3 | 0 | 0 | 6 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for OVID as an investment opportunity.
- The average analyst price target of OVID is higher than 7.19% of all US stocks.
- The variance in analysts' estimates of OVID is less than 15.2% of stocks in the small market cap category.
- Ovid Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 24.34% of Pharmaceutical Products stocks.
- OVID has a greater number of analysts covering the stock than 33.99% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, RUBY, OGN and RXRX are the three stocks most similar to Ovid Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding OVID using the data that counts. Try POWR Ratings for free.